Clinical study for improving local inflammatory response in patients with plasma cell mastitis abscess by external application of Chuang-Ling-Ye

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800017744

Enrollment

Unknown

Registered

2018-08-12

Start date

2018-09-01

Completion date

Unknown

Last updated

2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plasma Cell Mastitis

Interventions

treatment groups:Clean the abscess, sinus or fistula, acute or chronic inflammatory mass by Chuang-Ling-Ye

control groups:Clean the abscess, sinus or fistula, acute or chronic inflammatory mass by NS 30ml

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. The coexistence of abscess, sinus or fistula, acute or chronic inflammatory mass, acute attack and/or recurrent attack; 2. aged 18-60 year old female patients.

Exclusion criteria

Exclusion criteria: 1. lactating women and pregnant women; 2. patients with rheumatoid arthritis, dermatomyositis and other immune diseases; 3. combined with severe primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system. 4. patients suffering from mental illness; 5. With smoking history 6. Patients with severe organic diseases. 7. With history of hypothyroidism or hyperthyroidism. 8. hormone or immunosuppressive therapy was applied in the previous month. 9. allergy and allergy to the drug.

Design outcomes

Primary

Measure	Time frame
IL-2;IL-4;IL-6;TNF-a;Concentration of metalloproteinase;	—

Countries

China

Contacts

Public ContactYe Bei

Affiliated Hospital of Nanjing University of TCM

tina791018@hotmail.com+86 13951808751

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026